Voglio sapere a riguardo di…

lotter on DSK11XQN23PROD with NOTICES1

Federal Register / Vol. 86, No. 168 / Thursday, September 2, 2021 / Notices represent a nationwide average of consumer purchase prices, net of discounts and rebates. The contractor shall provide notification when a drug product becomes generally available and that the contract include such terms and conditions as the Secretary shall specify, including a requirement that the vendor monitor the marketplace.
CMS has developed a National Average Drug Acquisition Cost NADAC for states to consider when developing reimbursement methodology. The NADAC is a pricing benchmark that is based on the national average costs that pharmacies pay to acquire Medicaid covered outpatient drugs. This pricing benchmark is based on drug acquisition costs collected directly from pharmacies through a nationwide survey process.
This survey is conducted on a monthly basis to ensure that the NADAC
reference file remains current and up-todate. Form Number: CMS10241 OMB
control number 09381041; Frequency:
Monthly; Affected Public: Private sector Business or other for-profits; Number of Respondents: 72,000; Total Annual Responses: 72,000; Total Annual Hours:
36,000. For policy questions regarding this collection contact: Lisa Shochet at 4107865445.
2. Type of Information Collection Request: Extension of a currently approved collection; Title of Information Collection: Collection of Prescription Drug Event Data From Contracted Part D Providers for Payment; Use: The PDE data is used in the Payment Reconciliation System to perform the annual Part D payment reconciliation, any PDE data within the Coverage Gap Phase of the Part D benefit is used for invoicing in the CGDP, and the data are part of the report provided to the Secretary of the Treasury for Section 9008.
CMS has used PDE data to create summarized dashboards and tools, including the Medicare Part D Drug Spending Dashboard & Data, the Part D
Manufacturer Rebate Summary Report, and the Medicare Part D Opioid Prescribing Mapping Tool. The data are also used in the Medicare Trustees Report. Due to the market sensitive nature of PDE data, external uses of the data are subject to significant limitations. However, CMS does analyze the data on a regular basis to determine drug cost and utilization patterns in order to inform programmatic patterns and to develop informed policy in the Part D program.
The information users will be Pharmacy Benefit Managers PBMs, third party administrators and pharmacies, and the PDPs, MAPDs, Fallbacks and other plans that offer
VerDate Sep<11>2014

17:33 Sep 01, 2021

Jkt 253001

coverage of outpatient prescription drugs under the Medicare Part D benefit to Medicare beneficiaries. The statutorily required data is used primarily for payment and is used for claim validation as well as for other legislated functions such as quality monitoring, program integrity and oversight. Form Number: CMS10174
OMB control number: 09380982;
Frequency: Yearly; Affected Public:
Businesses or other for-profits, Not-forprofit institutions; Number of Respondents: 739; Total Annual Responses: 1,499,238,090; Total Annual Hours: 2,998. For policy questions regarding this collection contact Ivan Iveljic at 4107863312.
Dated: August 30, 2021.
William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs.
FR Doc. 202119012 Filed 9121; 8:45 am BILLING CODE 412001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and Families Privacy Act of 1974; Matching Program Administration for Children and Families, Department of Health and Human Services.
ACTION: Notice of a re-established matching program.
AGENCY:

In accordance with the Privacy Act of 1974, as amended, the Department of Health and Human Services, Administration for Children and Families, Office of Planning, Research, and Evaluation HHS/ACF/
OPRE, is providing notice of a reestablished matching program between the Department of Defense, Defense Manpower Data Center DoD/DMDC
and State Public Assistance Agencies SPAAs, Verification of Continued Eligibility for Benefits Through the Public Assistance Reporting Information System PARIS Program. HHS/ACF/
OPRE facilitates the matching program.
DATES: The deadline for comments on this notice is October 4, 2021. The reestablished matching program will commence not sooner than 30 days after publication of this notice, provided no comments are received that warrant a change to this notice. The matching program will be conducted for an initial term of 18 months from approximately September 30, 2021, through March 30, 2023 and within 3 months of expiration may be renewed for 1 additional year if SUMMARY:

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

49333

the parties make no change to the matching program and certify that the program has been conducted in compliance with the matching agreement.
Interested parties may submit written comments on this notice, by mail or email, to the Director, Division of Data and Improvement, HHS/ACF Office of Planning, Research, and Evaluation, 330 C Street SW, Washington, DC 20201, paris@
acf.hhs.gov.

ADDRESSES:

FOR FURTHER INFORMATION CONTACT:

General questions about the matching program may be submitted to Alicia Gumbs, HHS/ACF Office of Planning, Research, and Evaluation, 330 C Street SW, Washington, DC 20201 202 690
8490, paris@acf.hhs.gov.
The Privacy Act of 1974, as amended 5
U.S.C. 552a, subsectione12, provides certain protections for individuals applying for and receiving Federal benefits. The law governs the use of computer matching by Federal agencies when records in a system of records meaning, Federal agency records about individuals retrieved by name or other personal identifier are matched with records of other Federal or non-Federal agencies. The Privacy Act requires agencies involved in a matching program to:
1. Enter into a written agreement, which must be prepared in accordance with the Privacy Act, approved by the Data Integrity Board of each source and recipient Federal agency, provided to Congress and the Office of Management and Budget OMB, and made available to the public, as required by 5 U.S.C.
552ao, u3A, and u4.
2. Notify the individuals whose information will be used in the matching program that the information they provide is subject to verification through matching, as required by 5
U.S.C. 552ao1D.
3. Verify match findings before suspending, terminating, reducing, or making a final denial of an individuals benefits or payments or taking other adverse action against the individual, as required by 5 U.S.C. 552ap.
4. Report the matching program to Congress and the OMB, in advance and annually, as required by 5 U.S.C.
552ao 2Ai, r, and u3D.
5. Publish advance notice of the matching program in the Federal Register as required by 5 U.S.C.
552ae12.

SUPPLEMENTARY INFORMATION:

E:FRFM02SEN1.SGM

02SEN1